COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,970 Articles (22,604 medRxiv, 8,366 bioRxiv)

Most recent first Previous |  Page 164: Articles 1631-1640  | Next

IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo
Ghimire, S., Xue, B., Li, K., Gannon, R. M., Wohlford-Lenane, C. L., Thurman, A. L., Gong, H., Necker, G. C., Zheng, J., Meyerholz, D. K., Perlman, S., McCray, P. B., Pezzulo, A. A.
10.1101/2024.07.03.601941 — Posted: 2024-07-04
Developing, characterizing and modelingCRISPR-based point-of-use pathogen diagnostics
Jung, J. K., Dreyer, K. S., Dray, K. E., Muldoon, J. J., George, J., Shirman, S., Cabezas, M. D., D'Aquino, A. E., Verosloff, M. S., Seki, K., Rybnicky, G. A., Alam, K. K., Bagheri, N., Jewett, M. C., Leonard, J. N., Mangan, N. M., Lucks, J. B.
10.1101/2024.07.03.601853 — Posted: 2024-07-03
An HERV-W ENV transcription in atypical memory B cells linked to COVID-19 evolution and risk for long COVID can express the encoded protein from a ribosome readthrough of mRNA from chromosome X.
Brunel, J., Paganini, J., Galloux, M., CHARVET, B., Perron, H.
10.1101/2024.07.03.24309822 — Posted: 2024-07-03
Dispersal history of SARS-CoV-2 variants Alpha, Delta, and Omicron (BA.1) in Spain
Gallego-Garcia, P., Hong, S. L., Bollen, N., Dellicour, S., Baele, G., Suchard, M. A., Lemey, P., Posada, D.
10.1101/2024.07.01.24309632 — Posted: 2024-07-02
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Nguyen Thanh, P., Du, D. H., Hai, H. B., Nguyen, N. T., Khoa, L. D. V., Khanh, L. T. T., Tran, L. H. B., Linh, N. T. M., Van, C. T. C., Thao, D. P., Trinh, N. T. D., Kieu, P. T., Truong, N. T., Hoang, V. T., Ngoc, N. T., Vien, T. T. D., Ly, V. T., Khoa, T. D., Beane, A., Anibal, J. T., Thwaites, G., Geskus, R. B., Clifton, D., Dung, N. T. P., Kestelyn, E., Glover, G., Tan, L. V., Yen, L. M., Tung, N. L. N., Dung, N. T., Thwaites, C. L.
10.1101/2024.06.30.24309722 — Posted: 2024-07-01
Trends in Sudden Cardiac Death in Pilots: A Post COVID-19 Challenging Crisis of Global Perspectives (2011-2023)
Borges, J. Y. V.
10.1101/2024.06.29.24309708 — Posted: 2024-07-01
PARP14 mediated SQSTM1/p62 cysteine ADP-ribosylation is counteracted by the SARS-CoV-2 macrodomain
Kubon, D., Leslie Pedrioli, D. M., Hottiger, M. O.
10.1101/2024.06.29.601315 — Posted: 2024-07-01
Differential action modes of Neutrophil Extracellular Trap-targeted drugs define T cell responses in SARS-CoV-2 infection.
Bonilha, C. S., Veras, F. P., Ramos, A. d. S., Gomes, G. F., Lemes, R. M. R., Arruda, E., Alves-Filho, J. C., Cunha, T. M., Cunha, F. d. Q.
10.1101/2024.06.30.601403 — Posted: 2024-07-01
From HHV-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.
Maes, M., Almulla, A. F., Tang, X., Stoyanova, K., Vojdani, A.
10.1101/2024.06.28.24309682 — Posted: 2024-06-30
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
Hollister, J., Porter, C., Sprissler, R., Beitel, S. C., Romine, J. K., Uhrlaub, J. L., Grant, L., Yoo, Y. M., Fowlkes, A., Britton, A., Olsho, L. E. W., Newes-Adeyi, G., Fuller, S., Zheng, P. Q., Gaglani, M. G., Rose, S., Dunnigan, K., Naleway, A. L., Gwynn, L., Caban-Martinez, A., Schaefer Solle, N., Tyner, H. L., Philips, A. L., Hegmann, K. T., Yoon, S., Lutrick, K., Burgess, J. L., Ellingson, K. D.
10.1101/2024.06.28.24309655 — Posted: 2024-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).